PEER-REVIEWED PUBLICATIONS:

 

1. Feuer R. Tickling the CD200 receptor: A remedy for those irritating macrophages. Am. J. Path. In Press.

 

2. Feuer R, Whitton JL. Preferential coxsackievirus replication in proliferating/activated cells:  implications for virus tropism, persistence, and pathogenesis. Curr. Top. Microbiol. Immunol. Accepted For Publication.

 

3. Burrer R, Buchmeier MJ, Wolfe T, Ting J, Rempel JD, Feuer R, Rodrigo E, Weaver K, Hughes A, Iglesias A, von Herrath MG. Exacerbated pathology of viral encephalitis in mice with CNS-specific autoantibodies. Am. J. Pathol. 170: 557-   566, 2007.

 

4. Liu F, Feuer R, Hassett DE, Whitton JL. Peptide vaccination of a virus-immune recipient may cause serious CD8+ T cell mediated, TNF-dependent, immunopathology. J. Clin. Invest. 116:465-475, 2006.

 

5. Whitton JL, Cornell CT, Feuer R. Host and virus determinants of picornavirus pathogenesis and tropism. Nature Rev. Microbiology. 3:765-776, 2005.

 

6. Feuer R, Pagarigan RR, Harkins S, Liu F, Hunziker IP, Whitton JL. Coxsackievirus targets proliferating neuronal progenitor cells in the neonatal CNS. J. Neurosci. 25: 2434-2444, 2005.

 

7. Whitton JL, Feuer R. Myocarditis, microbes, and autoimmunity. Autoimmunity. 37: 375-386, 2004.

 

8. Hunziker IP, Harkins S, Feuer R, Cornell CT, Whitton JL. Generation and analysis of an RNA vaccine that protects against coxsackievirus B3 challenge. Virology. 330:196-208, 2004.

 

9. Feuer R, Mena I, Pagarigan RR, Hassett DE, Whitton JL. Coxsackievirus replication and the cell cycle: a potential regulatory mechanism for viral persistence/latency. Med. Microbiol. Immunol. 193:83-90, 2004.

 

10. Feuer R, Mena I, Pagarigan RR, Harkins S, Hassett DE, Whitton JL. Coxsackievirus B3 and the neonatal CNS: the roles of stem cells, developing neurons,and apoptosis in infection, viral dissemination, and disease. Am. J. Pathol. 163:1379-93, 2003.

 

11. Feuer R, Mena I, Pagarigan R, Slifka M, Whitton JL. Cell cycle status affects coxsackievirus replication, persistence, and reactivation in vitro. J. Virol. 76:4430-   4440, 2002.

 

12. Slifka M, Pagarigan R, Mena I, Feuer R, Whitton JL. Using recombinant coxsackievirus B3 to evaluate the induction and protective efficacy of CD8+ T cells during picornavirus infection. J. Virol. 75:2377-87, 2001.

 

13. Feuer R, Boone J, Netski D, Morzunov S, St. Jeor SC. Temporal and spatial analysis of Sin Nombre virus quasispecies in naturally infected rodents. J. Virol. 73:9544-9554, 1999.

 

14. Feuer G, Fraser JK, Zack JA, Lee F, Feuer R, Chen ISY. Human T-cell leukemia virus infection of human hematopoietic progenitor cells:  maintenance of virus infection during differentiation in vitro and in vivo. J. Virol. 70:4038-4044, 1996.

 

15. Feuer G, Stewart SA, Lee F, Feuer R, Chen ISY. Potential role of natural killer cells in controlling tumorigenesis by human T-cell leukemia viruses. J. Virol. 69:1328-1333, 1995.

 

MANUSCRIPTS SUBMITTED:

 

1. Feuer R, An N, Pagarigan RR, Cornell CT, Crocker SJ, Kiosses WB, Pham-Mitchell N, Campbell IL, Whitton JL. Coxsackievirus infection during the neonatal period leads to viral persistence and chronic immunopathology in the adult CNS.

 

MANUSCRIPTS IN PREPARATION:

 

1. Feuer R, Cornell CT, An N, Pagarigan RR, Harkins S, Rodriguez MP, Whitton JL. A novel population of myeloid cells responding to coxsackievirus infection in the neonatal CNS express a neural stem cell marker.

 

2. Feuer R, Crocker SJ, Milner R, An N, Frausto RF, Whitton JL. Efficient coxsackievirus replication and persistence in neurospheres.